The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ampio Pharmaceuticals, Inc(NYSE MKT:AMPE) 
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for...
Website: http://www.ampiopharma.com
Founded: 2008
Full Time Employees: 23
Sector: Healthcare
Industry: Biotechnology
Ampio Pharmaceuticals Days Payable Outstanding ttm (DPO)
Ampio Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Ampio Pharmaceuticals Op Cashflow Per Share ttm
Ampio Pharmaceuticals Free Cashflow Per Share ttm
Ampio Pharmaceuticals Cash Per Share ttm
Ampio Pharmaceuticals (GAAP) P/E ratio ttm
Ampio Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.